Members
Lawrence Band
Larry Band is the Ernest Ern Professor of Environmental Science and Professor of Civil and Environmental Engineering at the University of Virginia. Until 2017 he was the Voit Gilmore Distinguished Professor and Director of the Institute for the Environment at the University of North Carolina, Chapel Hill. Band’s research is on watershed ecohydrology, including coupled water, carbon and nutrient cycling, co-evolution of forest ecological and hydrological systems, and human/environment interactions, including water/health issues. Band is an AGU and GSA Fellow. In 2014 Band was the GSA Birdsall-Dreiss Distinguished Lecturer, with talks on hydroclimate and groundwater mediated evolution of forest patterns, and the ecohydrology of urban green infrastructure. He was the Consortium of Universities for the Advancement of Hydrologic Science, Inc. Board Chair in 2010. Band has been PI or co-PI on more than $30M of grants and contracts from municipal, state, federal and international agencies and foundations. Band has published >150 papers, book chapters and technical reports and has consulted with federal, state and municipal agencies in the US and Canada on watershed protection, forest health, stormwater and ecosystem restoration.
Larry Band is the Ernest Ern Professor of Environmental Science and Professor of Civil and Environmental Engineering at the University of Virginia. Until 2017 he was the Voit Gilmore Distinguished Professor and Director of the Institute for the Environment at the University of North Carolina, Chapel Hill. Band’s research is on watershed ecohydrology, including coupled water, carbon and nutrient cycling, co-evolution of forest ecological and hydrological systems, and human/environment interactions, including water/health issues. Band is an AGU and GSA Fellow. In 2014 Band was the GSA Birdsall-Dreiss Distinguished Lecturer, with talks on hydroclimate and groundwater mediated evolution of forest patterns, and the ecohydrology of urban green infrastructure. He was the Consortium of Universities for the Advancement of Hydrologic Science, Inc. Board Chair in 2010. Band has been PI or co-PI on more than $30M of grants and contracts from municipal, state, federal and international agencies and foundations. Band has published >150 papers, book chapters and technical reports and has consulted with federal, state and municipal agencies in the US and Canada on watershed protection, forest health, stormwater and ecosystem restoration.
Laura Barnes
Laura Barnes is an Associate Professor in Systems Engineering and Data Science. She directs the Sensing Systems for Health Lab. Her research focuses on the design of intelligent systems for understanding the dynamics and personalization of health and well-being. Fusing computational methods with technology such as smartphones and wearables, her group studies how macro and micro-level human behaviors manifest in the wild and how these behaviors relate to health. Her group's technology and methods have been applied to chronic diseases such as anxiety, depression, cancer, infectious disease, and traumatic brain injury. She received her Ph.D. degree in Computer Science. Her work has been funded by the National Institutes of Health, National Science Foundation, National Institute of Aerospace, Defense Advanced Research Projects, US Army, and private foundations.
Laura Barnes is an Associate Professor in Systems Engineering and Data Science. She directs the Sensing Systems for Health Lab. Her research focuses on the design of intelligent systems for understanding the dynamics and personalization of health and well-being. Fusing computational methods with technology such as smartphones and wearables, her group studies how macro and micro-level human behaviors manifest in the wild and how these behaviors relate to health. Her group's technology and methods have been applied to chronic diseases such as anxiety, depression, cancer, infectious disease, and traumatic brain injury. She received her Ph.D. degree in Computer Science. Her work has been funded by the National Institutes of Health, National Science Foundation, National Institute of Aerospace, Defense Advanced Research Projects, US Army, and private foundations.
Christopher Barrett
Christopher L. Barrett is Professor and Executive Director of the Biocomplexity Institute & Initiative at the University of Virginia. He is an interdisciplinary computational scientist who has published more than 100 research articles exploring all aspects of large multiscale interaction systems. Over the past 35 years, Barrett has conceived, founded and led large interdisciplinary complex systems research projects and organizations, established national and international technology programs, and co-founded organizations for federal agencies such as the Department of Defense, the Department of Energy and the Department of Homeland Security. He has served in various advisory and collaborative scientific roles internationally.
Barrett is the recipient of the 2012–2013 Jubilee Professorship in Computer Science and Engineering at Chalmers University in Sweden and is a member of the 2010 Royal Colloquium for the King of Sweden. He was a distinguished international professor at the Royal Institute of Technology in Stockholm (1997–1998). He has received Distinguished Research, Service, Advisory and Security Awards from the U.S. Navy, Los Alamos National Laboratory, Alliance for Transportation Research, as well as the Commonwealth of Virginia and European Commission. He holds seven patents and has nine pending.
https://engineering.virginia.edu/faculty/christopher-l-barrett
Christopher L. Barrett is Professor and Executive Director of the Biocomplexity Institute & Initiative at the University of Virginia. He is an interdisciplinary computational scientist who has published more than 100 research articles exploring all aspects of large multiscale interaction systems. Over the past 35 years, Barrett has conceived, founded and led large interdisciplinary complex systems research projects and organizations, established national and international technology programs, and co-founded organizations for federal agencies such as the Department of Defense, the Department of Energy and the Department of Homeland Security. He has served in various advisory and collaborative scientific roles internationally.
Barrett is the recipient of the 2012–2013 Jubilee Professorship in Computer Science and Engineering at Chalmers University in Sweden and is a member of the 2010 Royal Colloquium for the King of Sweden. He was a distinguished international professor at the Royal Institute of Technology in Stockholm (1997–1998). He has received Distinguished Research, Service, Advisory and Security Awards from the U.S. Navy, Los Alamos National Laboratory, Alliance for Transportation Research, as well as the Commonwealth of Virginia and European Commission. He holds seven patents and has nine pending.
https://engineering.virginia.edu/faculty/christopher-l-barrett
Ruth Gaare Bernheim
Ruth Gaare Bernheim is the William Hobson Professor and Chair of the Department of Public Health Sciences, School of Medicine, and Co-Director of the Institute for Practical Ethics and Public Life at the University of Virginia. She holds joint appointments in the Batten School of Leadership and Public Policy and the School of Law. Bernheim is the director of the Research Methods Core for the Translational Health Research Institute of Virginia (THRIV) where she leads the program to provide high quality biostatistics and regulatory support for clinical and translational research at UVA. She is the founding director of the Master of Public Health Program at the University of Virginia. Bernheim teaches courses in the medical, law, and engineering schools on public health law and policy and ethics, including in the required fourth-year medical school course on health policy. She is director of the Certificate Program in Public Health Sciences for Graduate Medical Education and led university-wide efforts to develop the undergraduate Global Public Health Minor and Global Public Health Major programs. Bernheim served recently as chair of the Center for Disease Control and Prevention’s (CDC) Ethics Subcommittee; as a member of the CDC Board of Scientific Counselors, Office of Public Health Preparedness and Response (OPHPR), and the National Board of Public Health Examiners; and as president of the Virginia Public Health Association. Bernheim currently serves on the 10-member Board of Councilors of the Council of Education for Public Health (CEPH), the official independent agency recognized by the US Department of Education to accredit schools and programs of public health. Her research interests focus on ethics, law and public health policy, health disparities and public-health community needs assessment.
Ruth Gaare Bernheim is the William Hobson Professor and Chair of the Department of Public Health Sciences, School of Medicine, and Co-Director of the Institute for Practical Ethics and Public Life at the University of Virginia. She holds joint appointments in the Batten School of Leadership and Public Policy and the School of Law. Bernheim is the director of the Research Methods Core for the Translational Health Research Institute of Virginia (THRIV) where she leads the program to provide high quality biostatistics and regulatory support for clinical and translational research at UVA. She is the founding director of the Master of Public Health Program at the University of Virginia. Bernheim teaches courses in the medical, law, and engineering schools on public health law and policy and ethics, including in the required fourth-year medical school course on health policy. She is director of the Certificate Program in Public Health Sciences for Graduate Medical Education and led university-wide efforts to develop the undergraduate Global Public Health Minor and Global Public Health Major programs. Bernheim served recently as chair of the Center for Disease Control and Prevention’s (CDC) Ethics Subcommittee; as a member of the CDC Board of Scientific Counselors, Office of Public Health Preparedness and Response (OPHPR), and the National Board of Public Health Examiners; and as president of the Virginia Public Health Association. Bernheim currently serves on the 10-member Board of Councilors of the Council of Education for Public Health (CEPH), the official independent agency recognized by the US Department of Education to accredit schools and programs of public health. Her research interests focus on ethics, law and public health policy, health disparities and public-health community needs assessment.
Sam Bodily
Samuel C. Bodily is the John Tyler Professor of Business Administration at the University of Virginia’s Darden School. His publications relate to decision and risk analysis, multiattribute utility, forecasting, strategy modeling, revenue management, and eStrategy. For the Institute of Global Infectious Diseases, his expertise can be applied to collaborations with those creating interventions in responding to an epidemic or outbreak, to help evaluate and weigh interventional options, and to make the development and disbursal of new therapeutics against global infectious diseases more palatable to manufacturers, government agencies, and NGOs. He has published textbooks and more than forty articles in top journals in the field.
Samuel C. Bodily is the John Tyler Professor of Business Administration at the University of Virginia’s Darden School. His publications relate to decision and risk analysis, multiattribute utility, forecasting, strategy modeling, revenue management, and eStrategy. For the Institute of Global Infectious Diseases, his expertise can be applied to collaborations with those creating interventions in responding to an epidemic or outbreak, to help evaluate and weigh interventional options, and to make the development and disbursal of new therapeutics against global infectious diseases more palatable to manufacturers, government agencies, and NGOs. He has published textbooks and more than forty articles in top journals in the field.
Catherine Bonham
Phillip Bourne
Philip E. Bourne, PhD, FACMI is the Stephenson Chair of Data Science, Director of the Data Science Institute and a Professor in the Department of Biomedical Engineering at the University of Virginia. Prior to that he was the Associate Director for Data Science (ADDS; aka Chief Data Scientist) for the National Institutes of Health (NIH) and a Senior Investigator at the National Center for Biotechnology Information (NCBI). In his role as ADDS he led the trans NIH US $110M per year Big Data to Knowledge (BD2K) research initiative and contributed to data policies and infrastructure aimed at accelerating biomedical discovery. Examples include: establishing the NIH Commons, support for data and software citation and establishing preprints as a supported form of research. Prior to joining NIH, Dr. Bourne was Associate Vice Chancellor for Innovation and Industry Alliances in the Office of Research Affairs and a Professor in the School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). Dr. Bourne is a Past President of the International Society for Computational Biology, an elected fellow of the American Association for the Advancement of Science (AAAS), the International Society for Computational Biology (ISCB), the American Medical Informatics Association (AMIA) and an inductee of the American Institute for Medical and Biological Engineering (AIMBE). He has published over 350 papers and 5 books and co-founded 4 companies. Awards include the Jim Gray Award eScience Award and the Benjamin Franklin Award. His current research focuses on systems pharmacology (notably neglected tropical diseases and protein kinase targets), structural bioinformatics, scholarly communication, professional development and the development and application of data science methods.
Philip E. Bourne, PhD, FACMI is the Stephenson Chair of Data Science, Director of the Data Science Institute and a Professor in the Department of Biomedical Engineering at the University of Virginia. Prior to that he was the Associate Director for Data Science (ADDS; aka Chief Data Scientist) for the National Institutes of Health (NIH) and a Senior Investigator at the National Center for Biotechnology Information (NCBI). In his role as ADDS he led the trans NIH US $110M per year Big Data to Knowledge (BD2K) research initiative and contributed to data policies and infrastructure aimed at accelerating biomedical discovery. Examples include: establishing the NIH Commons, support for data and software citation and establishing preprints as a supported form of research. Prior to joining NIH, Dr. Bourne was Associate Vice Chancellor for Innovation and Industry Alliances in the Office of Research Affairs and a Professor in the School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). Dr. Bourne is a Past President of the International Society for Computational Biology, an elected fellow of the American Association for the Advancement of Science (AAAS), the International Society for Computational Biology (ISCB), the American Medical Informatics Association (AMIA) and an inductee of the American Institute for Medical and Biological Engineering (AIMBE). He has published over 350 papers and 5 books and co-founded 4 companies. Awards include the Jim Gray Award eScience Award and the Benjamin Franklin Award. His current research focuses on systems pharmacology (notably neglected tropical diseases and protein kinase targets), structural bioinformatics, scholarly communication, professional development and the development and application of data science methods.
Thomas Braciale
Thomas Braciale is a Professor in the Department of Pathology. The Braciale laboratory has had a long-standing interest (over 30 years) in understanding the host response to respiratory viral infection and the role of the host innate and adaptive immune response in controlling virus infection and in producing tissue injury. His research has focused primarily on Influenza A Virus infection and infection with Respiratory Syncytial Virus but has in the past also explored bio defense issues relating to poxvirus infection. The Institute of Global Infectious Diseases represents a novel particularly exciting approach to dealing with the many issues relating to Infectious Diseases including human health, economic development and political instability. The 2009 influenza swine flu pandemic, the emergence of the MERS virus, the outbreak of Ebola in West Africa and more recently the spread of Zika virus infection in South and Central America highlight the importance of this global problem. The approaches envisioned in this initiative represent the appropriate multipronged strategy to deal with Global Infectious Diseases. Dr. Braciale is most enthusiastic about the prospect of this Institute and his participation in its activities.
Thomas Braciale is a Professor in the Department of Pathology. The Braciale laboratory has had a long-standing interest (over 30 years) in understanding the host response to respiratory viral infection and the role of the host innate and adaptive immune response in controlling virus infection and in producing tissue injury. His research has focused primarily on Influenza A Virus infection and infection with Respiratory Syncytial Virus but has in the past also explored bio defense issues relating to poxvirus infection. The Institute of Global Infectious Diseases represents a novel particularly exciting approach to dealing with the many issues relating to Infectious Diseases including human health, economic development and political instability. The 2009 influenza swine flu pandemic, the emergence of the MERS virus, the outbreak of Ebola in West Africa and more recently the spread of Zika virus infection in South and Central America highlight the importance of this global problem. The approaches envisioned in this initiative represent the appropriate multipronged strategy to deal with Global Infectious Diseases. Dr. Braciale is most enthusiastic about the prospect of this Institute and his participation in its activities.
Catherine Bradshaw
Catherine Bradshaw is a Professor and the Associate Dean for Research and Faculty Development at the Curry School of Education at the University of Virginia (U.Va.). Prior to her current appointment at Suva, she was an Associate Professor and the Associate Chair of the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health. She holds a doctorate in developmental psychology from Cornell University and a master’s of education in counseling and guidance from the University of Georgia. She is the editor of Prevention Science and formerly Associate Editor for the Journal of Research on Adolescence. She organizes Curry’s efforts in globally-themed research. Her primary research interests focus on youth development, bullying, and school-based prevention programs. Her expertise will benefit the ongoing and planned research in the Institute of Global Infectious Diseases on the effect of pediatric infectious diseases on child and adolescent health and development, and frame positive interventions in light of what works most effectively in this population.
Catherine Bradshaw is a Professor and the Associate Dean for Research and Faculty Development at the Curry School of Education at the University of Virginia (U.Va.). Prior to her current appointment at Suva, she was an Associate Professor and the Associate Chair of the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health. She holds a doctorate in developmental psychology from Cornell University and a master’s of education in counseling and guidance from the University of Georgia. She is the editor of Prevention Science and formerly Associate Editor for the Journal of Research on Adolescence. She organizes Curry’s efforts in globally-themed research. Her primary research interests focus on youth development, bullying, and school-based prevention programs. Her expertise will benefit the ongoing and planned research in the Institute of Global Infectious Diseases on the effect of pediatric infectious diseases on child and adolescent health and development, and frame positive interventions in light of what works most effectively in this population.
Michael G. Brown
Michael Brown is a Professor in the Department of Medicine. Dr. Brown’s primary research interest centers on the genetics of host resistance to viral infection and the role of NK cells in virus immunity. This stems from his early work with MHC-linked proteasome subunits and MHC class I antigen processing. His main research goals now are to understand (1) how genetic diversity shapes and regulates both innate and adaptive immune cells/responsiveness to infection, (2) how NK cell features and effector functionality are acquired and programmed by both genetic and environmental influences, and (3) how NK cells/responses to immune stimuli/target cells specifically affects and regulates adaptive immunity. His laboratory has learned that the MHC exerts substantial control over NK cells, and they have developed several valuable mouse models to examine this effect in much greater depth. They recently found that NK cell licensing, which is controlled by cellular MHC I expression patterns, can profoundly affect NK effector functions and their capacity to mediate virus resistance. While the molecular basis of NK cell licensing has not be delineated, this model system provides an outstanding resource and opportunity to identify and characterize the essential molecular determinants required to license NK cells. Thus, Dr. Brown’s research program provides an outstanding opportunity to establish international collaborations and for training future scientists, medical personnel, educators and policy makers. It also adds to the University's integrated portfolio of research in infectious diseases which can lead to additional multi-PI collaborations and grant awards.
Michael Brown is a Professor in the Department of Medicine. Dr. Brown’s primary research interest centers on the genetics of host resistance to viral infection and the role of NK cells in virus immunity. This stems from his early work with MHC-linked proteasome subunits and MHC class I antigen processing. His main research goals now are to understand (1) how genetic diversity shapes and regulates both innate and adaptive immune cells/responsiveness to infection, (2) how NK cell features and effector functionality are acquired and programmed by both genetic and environmental influences, and (3) how NK cells/responses to immune stimuli/target cells specifically affects and regulates adaptive immunity. His laboratory has learned that the MHC exerts substantial control over NK cells, and they have developed several valuable mouse models to examine this effect in much greater depth. They recently found that NK cell licensing, which is controlled by cellular MHC I expression patterns, can profoundly affect NK effector functions and their capacity to mediate virus resistance. While the molecular basis of NK cell licensing has not be delineated, this model system provides an outstanding resource and opportunity to identify and characterize the essential molecular determinants required to license NK cells. Thus, Dr. Brown’s research program provides an outstanding opportunity to establish international collaborations and for training future scientists, medical personnel, educators and policy makers. It also adds to the University's integrated portfolio of research in infectious diseases which can lead to additional multi-PI collaborations and grant awards.
Timothy Bullock
Timothy Bullock is an Associate Professor in the Department of Pathology. Dr. Bullock’s lab has a long-standing history of defining the mechanisms by which cytotoxic cells of the immune system, known as CD8+ T cells, are activated and differentiates. This is done with the intent to leverage this knowledge to develop molecules that augment the efficacy of vaccines, particular therapeutic vaccines that depend upon effector T cell activity. This knowledge and expertise will fit with intent of the Institute of Global Infectious Diseases to develop and deploy interventions that will be rapidly available to acute outbreaks of infectious disease. Dr. Bullock has managed grants from federal and philanthropic sources, and has a robust relationship with various entities in the biotechnological industries.
Timothy Bullock is an Associate Professor in the Department of Pathology. Dr. Bullock’s lab has a long-standing history of defining the mechanisms by which cytotoxic cells of the immune system, known as CD8+ T cells, are activated and differentiates. This is done with the intent to leverage this knowledge to develop molecules that augment the efficacy of vaccines, particular therapeutic vaccines that depend upon effector T cell activity. This knowledge and expertise will fit with intent of the Institute of Global Infectious Diseases to develop and deploy interventions that will be rapidly available to acute outbreaks of infectious disease. Dr. Bullock has managed grants from federal and philanthropic sources, and has a robust relationship with various entities in the biotechnological industries.